A clinical revision of gastro-oesophageal reflux disease (GORD)

Abstract

Gastro-oesophageal reflux disease (GORD) is a common problem in the adult population with an increasing prevalence of 30–40%. There is geographical variation but increasing prevalence across all populations with North America and Europe leading the burden of the disease.^1,2 Most humans are predisposed to at least one reflux episode per week of which the majority will be symptomatic, but not require any intervention. The Montreal Consensus Group defines the condition as when stomach refluxate causes troublesome symptoms and/or complications.^3,4